A Phase I, Single-Centre, Randomised, Open, Three-Way Crossover Study to Evaluate the Effect of Ketoconazole and Verapamil, Respectively, on the Pharmacokinetics of AZD1305 After Repeated Oral Adm [administration] of Ketoconazole and Verapamil and Single Oral Dosing of AZD1305 to Young Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 01 Sep 2016
At a glance
- Drugs AZD 1305 (Primary) ; Ketoconazole; Verapamil
- Indications Arrhythmias
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 22 Sep 2008 Status changed from recruiting to active, no longer recruiting, as reported in Clinicaltrials.gov record.
- 25 Jul 2008 New trial record.